29 reports

The Pharmaceuticals Division consists of two divisions: Roche Pharmaceuticals and Chugai.

  • Genitourinary System Disease
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.
  • KEY COMPANIES IN THE OSTEOPOROSIS MARKET IN THE 7MM, 2018

Springer-Verlag, ##(##), pp. ##-##. doi: ##. ##/ s##-##- ##-##.

  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.
  • Major Merger & Acquisitions in Renal Cell Carcinoma

RCC Market Patent Trend by Top Inventors Merck ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Pfizer ## ## ## ## ## ## ## ## ## ## ## ## ## ## Roche ## ## ## ## ## ## ## ## ## ## ## ## ## ## NIH ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Genentech ## ## ## ## ## ## ## ## ##

  • Pharmaceutical
  • Renal Cancer
  • Therapy
  • Company
  • Amgen Inc.

TABLE ##: PRODUCT PROFILE - TS-## TAHIO PHARMACEUTICALS' TS-## WAS APPROVED IN 2003 FOR THE TREATMENT OF MCRC.

  • Pharmaceutical
  • East Asia
  • United States
  • Company
  • Amgen Inc.
  • KEY COMPANIES IN THE PSORIASIS MARKET, 2015

INTERNATIONAL JOURNAL OF PHARMA WORLD RESEARCH; ##(##): ##-##.

  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.
  • S. No. Company

APPENDIX ##: LIST OF COMPANIES AND ORGANIZATIONS ##. ##ST ORDER PHARMACEUTICALS ##. ##ANDME ##. ##P THERAPEUTICS ##. ## DIMENSIONS CAPITAL ##.

  • Chronic Pain
  • Opioid
  • Pharmaceutical
  • Company
  • Amgen Inc.

International Journal of Pharma World Research; ##(##): ##-##.

  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.

International Journal of Pharma World Research; ##(##): ##-##.

  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.

International Journal of Pharma World Research; ##(##): ##-##.

  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.

International Journal of Pharma World Research; ##(##): ##-##.

  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.

FIGURE ##. ## PRESENTS THE MOST PROMINENT VIRAL VECTORS THAT ARE BEING UTILIZED FOR DEVELOPING GENE THERAPIES TARGETING VARIOUS ONCOLOGICAL INDICATIONS. ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Gene Therapy
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.

Immunohematology, ##(##), ##-## < PMID> ##< / PMID>.

  • Blood Disease
  • Pharmaceutical
  • North America
  • Company
  • Amgen Inc.

Rheumatoid arthritis

4385 5000 3900

Physicians were asked to rank a number of treatment challenges in RA on a scale of ## to ##, with ## being the highest priority challenge and ## being the lowest priority challenge for the pharmaceutical industry to address.

  • Arthritis
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.

KITE PHARMA: THE BASIC PROCESS INVOLVED IN EACT MANUFACTURING INCLUDES: ##.

  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.

Colorectal cancer

4385 5000 3900

PloS One, ##(##), e##.

  • Colorectal Cancer
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.

Psoriatic arthritis

4385 5000 3900

Pharmaceuticals Policy and Law, ##, ##-##.

  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.
  • Competitive Assessment
  • 9 Appendix

Spain - Pharmaceutical.

  • Pharmaceutical
  • China
  • United States
  • Company
  • Amgen Inc.
  • 9 Appendix

Spain - Pharmaceutical.

  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.
  • Competitive Assessment
  • 9 Appendix

Spain - Pharmaceutical.

  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.
  • Competitive Assessment
  • 9 Appendix

Spain - Pharmaceutical.

  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES

Osteoarthritis - Overview Osteoarthritis - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR OSTEOARTHRITIS, H## 2018 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR OSTEOARTHRITIS, H## 2018 Phase III ## ## Phase II ## ## Phase I ## ## IND/ CTA Filed ## ## Pre

  • Arthritis
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.

Melanoma

4385 5000 3900

Opdivo became the first PD-## inhibitor to reach the market when it was approved for the treatment of melanoma in Japan in July 2014 (Ono Pharmaceutical press release, 2014a).

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, OSTEOPOROSIS
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, OSTEOARTHRITIS

Post Menopausal Osteoporosis - Overview Therapeutics Development OSTEOARTHRITIS PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR OSTEOARTHRITIS NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR OSTEOARTHRITIS Pre-Registration ## ## Filing rejected/ Withdrawn ## ## Phase III ## ## Ph

  • Arthritis
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Company
  • Amgen Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2016
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2016

(Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceuticals.

  • Pharmaceutical
  • Turkey
  • United States
  • Company
  • Amgen Inc.
  • MERGERS & ACQUISITIONS
  • This information included according to the S-1 of Anthera Pharmaceuticals, Inc. dated November 8, 2010.

Amgen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Amgen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments,...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.
  • MERGERS & ACQUISITIONS
  • This information included according to the S-1 of Anthera Pharmaceuticals, Inc. dated November 8, 2010.

Amgen, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Amgen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments,...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Company
  • Amgen Inc.
  • COMPANY INFORMATION: PARTNERS
  • COMPANY INFORMATION: PARTNERS

Pharmaceuticals and Healthcare--> Therapy Area--> Oncology Pharmaceuticals and Healthcare--> Therapy Area-- > Immunology and Inflammation Pharmaceuticals and Healthcare--> Biotechnology--> Enabling Technology One Amgen Center Drive Thousand Oaks Califo

  • Healthcare
  • Pharmaceutical
  • Denmark
  • Company
  • Amgen Inc.

Psoriasis

4385 5000 3900

Pharmaceuticals Policy and Law, ##, ##-##.

  • Pharmaceutical
  • Japan
  • United States
  • Company
  • Amgen Inc.
  • Corporate Profile

A PHARMACEUTICAL PRODUCT IS GENERALLY ONE THAT IS MADE UP USING AVAILABLE CHEMICAL COMPOUNDS.

  • Pharmaceutical
  • Therapy
  • United States
  • Company
  • Amgen Inc.